The Challenge of Breast Density– Options for Management and Breast Cancer Screening

Meagan Brennan (1), Brooke Nickel (2), Nehmat Houssami (3)
(1) Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW AND School of Medicine, Sydney, University of Notre Dame, Sydney, NSW, Australia,
(2) Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia,
(3) Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia

Abstract

N/A

Full text article

Generated from XML file

References

Boyd NF, Guo H, Martin LJ, Sun L, Stone J, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227-36.

Alipour S, Bayani L, Saberi A, Alikhassi A, Hosseini L, et al. Imperfect correlation of mammographic and clinical breast tissue density. Asia Pac J Cancer Prev. 2013;14:3685-8.

American College of Radiology (ACR). ACR BI-RADS Atlas 5th Edition. ACR; 2013.

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, et al. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2016;164(4):268-78.

Wang AT, Vachon CM, Brandt KR, Ghosh K, editors. Breast density and breast cancer risk: a practical review. Mayo Clinic Proceedings; 2014: Elsevier.

Lee CI, Chen LE, Elmore JG. Risk-based Breast Cancer Screening: Implications of Breast Density. Med Clin North Am. 2017;101(4):725-41.

Cancer Australia. Position statement on breast density and screening within the BreastScreen Australia Program. 2016; Guidelines for preventive activities in general practice. The Red Book, 9th Edition. 2020.

UK National Screening Committee. Additional screening with ultrasound after negative mam-mography screening in women with dense breasts. United Kingdom: UK National Screening Committee; 2019.

Brennan ME. Breast tomosynthesis: a fine balance between benefits and harms in breast cancer screening. The Medical journal of Australia. 2019;211(8):349.

Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, et al. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density. JAMA Oncol. 2019;5(5): 635-42.

Marinovich ML, Hunter KE, Macaskill P, Houssami N. Breast cancer screening using tomosynthesis or mammography: a meta-analysis of cancer detection and recall. JNCI: Journal of the National Cancer Institute. 2018; 110(9):942-9.

Scheel JR, Lee JM, Sprague BL, Lee CI, Lehman CD. Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. American journal of obstetrics and gynecology. 2015;212(1):9-17.

Berg WA. Tailored supplemental screening for breast cancer: what now and what next? American Journal of Roentgenology. 2009;192(2):390-9.

Zanotel M, Bednarova I, Londero V, Linda A, Lorenzon M, et al. Automated breast ultrasound: basic principles and emerging clinical applications. La radiologia medica. 2018;123(1): 1-12.

Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PH, et al. Supplemental MRI screening for women with extremely dense breast tissue. New England Journal of Medicine. 2019;381(22):2091-102.

Kuhl CK. Abbreviated magnetic resonance imaging (MRI) for breast cancer screening: rationale, concept, and transfer to clinical practice. Annual Review of Medicine. 2019;70: 501-19.

Houssami N, Lee CI. The impact of legislation mandating breast density notification–Review of the evidence. The Breast. 2018;42:102-12.

Authors

Meagan Brennan
meagan.brennan@sydney.edu.au (Primary Contact)
Brooke Nickel
Nehmat Houssami
1.
Brennan M, Nickel B, Houssami N. The Challenge of Breast Density– Options for Management and Breast Cancer Screening. Arch Breast Cancer [Internet]. 2020 Nov. 16 [cited 2025 Jan. 22];:145-8. Available from: https://archbreastcancer.com/index.php/abc/article/view/328

Article Details